Krishna Institute of Medical Sciences Ltd

- KIMS Hospitals is planning a Qualified Institutional Placement (QIP) to raise around INR 1,500 crores. - The QIP proceeds will primarily be used to retire debt (around INR 1,000 crores) and support some losses and additional CAPEX in existing facilities. - The current net debt is around INR 3,000 crores post-QIP, and the goal is to bring the net debt to EBITDA ratio from 1:3 down to a healthier 1:2 level. - The company intends to use freed-up cash flow post-debt reduction to fund greenfield expansions, primarily in Karnataka, Kerala, Andhra Pradesh, and Telangana. - Doctor participation in funding remains a small, ongoing part of capital raising (3-5%) but is not a focus in current expansion plans. - No specific forward-looking numbers on growth guidance from the fundraising exercise were shared.

- The company plans steady expansion, including both Greenfield and Brownfield projects, over the next 3-5 years. - Next 12-24 months focus on consolidating current hospitals and expanding margins. - Greenfield projects planned in Karnataka, Kerala, Tamil Nadu (1 new hospital), Andhra Pradesh, and Telangana. - Expansion involves adding more beds year-on-year; beds at Kondapur new facility to be commissioned in phases (400-500 beds in Phase 1, remaining 300 phased based on occupancy). - Remaining CAPEX of around INR 50-75 crores for Kondapur to be incurred in FY '28 and beyond. - Acquisitions of smaller hospitals (approx. 400-500 beds collectively) possible within next two quarters. - Raised funds through QIP intended primarily for retiring ~INR 1,000 crores debt and supporting CAPEX for existing facilities and losses. - Ramp-up expected to improve, reducing EBITDA erosion at new units. Overall, KIMS Hospitals aims for continued capacity expansion alongside debt reduction to maintain financial health.

- KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana. - New hospitals in Bangalore (Mahadevapuram, Electronic City) and Telangana (Kondapur, Kompally) are expected to ramp up and become EBITDA positive, contributing to volume-driven growth in the next 4-5 years. - IP and OP volumes grew by 15.4% and 25.4% respectively in FY '26, with sustained upward trends anticipated. - Bangalore hospitals' occupancy expected to reach 35-40% by end of next financial year, with ARPOB stabilizing around INR 75,000 initially and improving over time. - Telangana cluster anticipates healthy EBITDA growth of around 10%-12% in FY '27. - New units' losses expected to reduce by more than half in FY '27 and FY '28 as ramp-up and empanelments progress. - Focus remains on maintaining an optimal net debt to EBITDA ratio for financial health while supporting expansion.

- The company expects a steady expansion over the next 3 to 5 years, aiming to maintain similar growth levels as in the past five years. - EBITDA losses from new hospitals, currently around INR 120 crore annually, are expected to reduce to less than half in FY '27 and '28. - Telangana cluster to grow healthily with an estimated 10%-12% EBITDA growth in FY '27. - New units like Mahadevapuram and PES (Electronic City) in Bangalore are anticipated to become EBITDA positive before October and by end of financial year respectively. - Debt to EBITDA ratio targeted to reduce from current 1:3 to a healthier 1:2 to improve financial health. - Earnings metrics like PAT, EPS, ROE, and ROC dipped recently but expected to improve post-fundraising and operational stabilization. - Expansion focused on home markets—Karnataka, Kerala, Andhra Pradesh, Telangana—with greenfield and brownfield projects to drive future growth.

The transcript provided does not explicitly mention current or expected orderbook or pending orders for KIMS Hospitals. However, relevant information related to expansions and acquisitions includes: - Ongoing and planned expansions in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana with greenfield and brownfield projects. - Small acquisition opportunities totaling around 400-500 beds expected over the next two quarters. - Focus on ramping up new hospitals with delays primarily due to insurance empanelment processes rather than order inflows. - No explicit mention of order backlog or pending orders in the call. - Fundraising (QIP) aimed at lowering debt and supporting ongoing/ future expansion projects. Therefore, no specific figures or details on the orderbook/pending orders were disclosed in the transcript.